SCHEMBL1765901

SCHEMBL1765901

CC(=O)Oc1ccc(C(C)=CCc2nc(-c3ccc(Cl)cc3Cl)oc2C(C)C)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 8/20 0.50
PPARD Q03181 7/20 0.50
PPARG P37231 6/20 0.50
TSHR P16473 3/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDE4B Q07343 1/20 0.34
PDE11A Q9HCR9 1/20 0.34
MRGPRX4 Q96LA9 1/20 0.33
RARA P10276 2/20 0.32
RARB P10826 2/20 0.32
RARG P13631 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
ADRB2 P07550 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4754079 0.89 PPARD (0.62) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL1765952 0.88 PPARA (0.54) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL6888019 0.87 PPARG (0.49) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL4755232 0.86 PPARA (0.46) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL4752344 0.85 PPARA (0.55) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL6885086 0.84 PPARA (0.53) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL6888012 0.81 PPARA (0.48) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL6888014 0.81 PPARA (0.48) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL4754218 0.79 PPARA (0.49) PPARAPPARDPPARGTSHRHSD17B10
SCHEMBL4755223 0.79 PPARA (0.53) PPARAPPARDPPARGTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2464349-A2 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES Cerenis Therapeutics S.A. (FR) 2012-06-20 EP disclosed
WO-2011020001-A9 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES CERENIS THERAPEUTICS S.A. (FR) 2011-05-26 WO disclosed
WO-2011020001-A2 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES CERENIS THERAPEUTICS S.A. (FR) 2011-02-17 WO disclosed
WO-2008154023-A1 NOVEL USES OF PPAR DELTA AGONISTS CERENIS THERAPEUTICS S.A. (FR) 2008-12-18 WO disclosed